gzr-18
Peptideexperimental
Clinical trial activity
20 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
12
Phase 2
10
Phase 3
4
Phase 4
0
Earliest trial started Dec 2, 2021 (NCT06548997)
Timeline
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07292441 | Phase 3 | Jan 31, 2026 | Gan and Lee Pharmaceuticals, USA |
| NCT07128888 | Phase 1 | Nov 17, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT07144098 | Phase 1 | Aug 12, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT07055386 | Phase 2 | Aug 7, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06974487 | Phase 1 | May 8, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT07119450 | Phase 1 | May 7, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT07141030 | Phase 1 | Apr 11, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06737042 | Phase 2 | Feb 12, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06777238 | Phase 3 | Jan 17, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06778967 | Phase 3 | Jan 7, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06728124 | Phase 3 | Dec 31, 2024 | Gan and Lee Pharmaceuticals, USA |
| NCT06670209 | Phase 1 | Oct 30, 2024 | Gan and Lee Pharmaceuticals, USA |
| NCT06554054 | Phase 1 | Apr 1, 2024 | Gan and Lee Pharmaceuticals, USA |
| NCT06256549 | Phase 2 | Aug 9, 2023 | Gan and Lee Pharmaceuticals, USA |
| NCT06256562 | Phase 2 | Jun 8, 2023 | Gan and Lee Pharmaceuticals, USA |
| NCT06548945 | Phase 1 | Apr 25, 2023 | Gan and Lee Pharmaceuticals, USA |
| NCT06256536 | Phase 1/Phase 2 (Phase 2) | Jul 14, 2022 | Gan and Lee Pharmaceuticals, USA |
| NCT06256523 | Phase 1/Phase 2 (Phase 2) | Jun 29, 2022 | Gan and Lee Pharmaceuticals, USA |
| NCT05328726 | Phase 1 | Mar 8, 2022 | Gan and Lee Pharmaceuticals, USA |
| NCT06548997 | Phase 1 | Dec 2, 2021 | Gan and Lee Pharmaceuticals, USA |
Showing 20 of 20 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gan and Lee Pharmaceuticals, USA | For profit | 20 | 20 | 3 | 2021 |
1 organizations
Page 1 / 1